|
Brucella species
(Brucellosis)
Read the Chapter
Sliding Table of
Contents on the left of the screen
Tables and
Figures
Table 1:
Minimal Inhibitory Concentration (ug/mL) of Cephalosporins against Brucella
Species
Table 2:
Minimal Inhibitory Concentrations (ug/mL) of Tetracyclines Against Brucella
Species
Table 3:
Minimal Inhibitory Concentrations (ug/mL) of Aminoglycosides Against
Brucella Species
Table 4:
Minimal Inhibitory Concentrations (ug/mL) of Co-trimoxazole Against
Brucella Species
Table 5:
Minimal Inhibitory Concentrations (ug/mL) of Rifampin Against Brucella
species
Table 6:
Minimal Inhibitory Concentrations (ug/mL) of Selected Quinolones Against
Brucella Species
Table 7.
Studies Comparing Antimicrobial Combinations in the Treatment of Brucellosis
Table 8:
Comparison of Antimicrobial Drugs for the Treatment of Childhood Brucellosis
Vignettes
Thomas
Benedek:
Brucellosis.
Colmenero JD, Ruiz-Mesa JD, et al.
Clinical Findings,
Therapeutic Approach, and Outcome of Brucellar Vertebral Osteomyelitis.
Clin Infect Dis 2008;46(3):426-33.
Review Article:
Adhikari P, Mietzner T. Cell Mediated Immunity. 2008.
Review Article: Pia Franco,M.,
Mulder, M., Gilman, R. and Smits, H. Human Brucellosis. The LANCET Infectious
Diseases 2007; Vol.7, Issue 12, 775-786.
Authors
Edward J. Young, M.D.
|
www.antimicrobe.org